Parmax Pharma Intrinsic Value
PARMAX Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹64.00 | ₹57.60 - ₹70.40 | +73.0% | Revenue/Share: ₹32.00, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹18.57 | ₹14.86 - ₹22.28 | -49.8% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check PARMAX share price latest .
Valuation Comparison Chart
PARMAX Intrinsic Value Analysis
What is the intrinsic value of PARMAX?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Parmax Pharma (PARMAX) is ₹64.00 (median value). With the current market price of ₹36.99, this represents a +73.0% variance from our estimated fair value.
The valuation range spans from ₹18.57 to ₹64.00, indicating ₹18.57 - ₹64.00.
Is PARMAX undervalued or overvalued?
Based on our multi-method analysis, Parmax Pharma (PARMAX) appears to be trading below calculated value by approximately 73.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.25 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | -9.50 | Industry Standard: <0.5 | Below 0.5 | Indicates financial leverage level |
| Return on Equity | 250.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -27.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.84x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Parmax Pharma
Additional stock information and data for PARMAX
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |